ESPR logo

Esperion Therapeutics (ESPR) Total Expenses

Annual Total Expenses

$271.90 M
+$16.92 M+6.64%

31 December 2023

ESPR Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$67.66 M
-$3.60 M-5.05%

30 September 2024

ESPR Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ESPR Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.6%+10.0%
3 y3 years-22.1%-3.6%
5 y5 years+32.9%+1.4%

ESPR Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-22.1%+6.6%-9.3%+11.6%
5 y5 years-22.1%+32.9%-35.7%+12.9%
alltimeall time-22.1%+2575.0%-35.7%+3031.9%

Esperion Therapeutics Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$67.66 M(-5.0%)
June 2024
-
$71.25 M(+8.8%)
Mar 2024
-
$65.47 M(-12.3%)
Dec 2023
$271.90 M(+6.6%)
$74.62 M(+21.3%)
Sept 2023
-
$61.50 M(-2.1%)
June 2023
-
$62.84 M(-13.8%)
Mar 2023
-
$72.93 M(+18.9%)
Dec 2022
$254.98 M(-16.4%)
$61.33 M(+1.2%)
Sept 2022
-
$60.60 M(-14.9%)
June 2022
-
$71.22 M(+15.2%)
Mar 2022
-
$61.83 M(-13.0%)
Dec 2021
$305.18 M(-12.5%)
$71.03 M(+1.2%)
Sept 2021
-
$70.15 M(-4.2%)
June 2021
-
$73.19 M(-19.4%)
Mar 2021
-
$90.80 M(-13.7%)
Dec 2020
$348.94 M(+44.5%)
$105.21 M(+24.7%)
Sept 2020
-
$84.38 M(+1.6%)
June 2020
-
$83.07 M(+8.9%)
Mar 2020
-
$76.29 M(+27.3%)
Dec 2019
$241.47 M(+18.0%)
$59.95 M(-10.2%)
Sept 2019
-
$66.75 M(+18.6%)
June 2019
-
$56.28 M(-3.8%)
Mar 2019
-
$58.49 M(-3.6%)
Dec 2018
$204.59 M(+21.1%)
$60.65 M(+19.9%)
Sept 2018
-
$50.56 M(+8.8%)
June 2018
-
$46.48 M(-0.9%)
Mar 2018
-
$46.89 M(+21.2%)
Dec 2017
$168.98 M
$38.70 M(-15.4%)
DateAnnualQuarterly
Sept 2017
-
$45.74 M(+4.8%)
June 2017
-
$43.66 M(+6.8%)
Mar 2017
-
$40.89 M(+39.6%)
Dec 2016
$76.15 M(+52.2%)
$29.29 M(+65.3%)
Sept 2016
-
$17.71 M(+23.6%)
June 2016
-
$14.33 M(-3.3%)
Mar 2016
-
$14.82 M(+12.0%)
Dec 2015
$50.04 M(+38.1%)
$13.23 M(+2.4%)
Sept 2015
-
$12.92 M(+3.7%)
June 2015
-
$12.46 M(+9.1%)
Mar 2015
-
$11.43 M(+21.8%)
Dec 2014
$36.22 M(+59.2%)
$9.38 M(-3.3%)
Sept 2014
-
$9.70 M(+4.8%)
June 2014
-
$9.25 M(+17.3%)
Mar 2014
-
$7.89 M(-19.0%)
Dec 2013
$22.76 M(+123.0%)
$9.74 M(+80.1%)
Sept 2013
-
$5.41 M(+26.6%)
June 2013
-
$4.27 M(+27.8%)
Mar 2013
-
$3.34 M(+54.8%)
Dec 2012
$10.20 M(+0.4%)
$2.16 M(-27.8%)
Sept 2012
-
$2.99 M(+4.4%)
June 2012
-
$2.86 M(+30.8%)
Mar 2012
-
$2.19 M
Dec 2011
$10.16 M(-65.2%)
-
Dec 2002
$29.24 M(-0.3%)
-
Dec 2001
$29.33 M(+6.4%)
-
Dec 2000
$27.57 M(+122.9%)
-
Dec 1999
$12.37 M
-

FAQ

  • What is Esperion Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Esperion Therapeutics?
  • What is Esperion Therapeutics annual total expenses year-on-year change?
  • What is Esperion Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Esperion Therapeutics?
  • What is Esperion Therapeutics quarterly total expenses year-on-year change?

What is Esperion Therapeutics annual total expenses?

The current annual total expenses of ESPR is $271.90 M

What is the all time high annual total expenses for Esperion Therapeutics?

Esperion Therapeutics all-time high annual total expenses is $348.94 M

What is Esperion Therapeutics annual total expenses year-on-year change?

Over the past year, ESPR annual total expenses has changed by +$16.92 M (+6.64%)

What is Esperion Therapeutics quarterly total expenses?

The current quarterly total expenses of ESPR is $67.66 M

What is the all time high quarterly total expenses for Esperion Therapeutics?

Esperion Therapeutics all-time high quarterly total expenses is $105.21 M

What is Esperion Therapeutics quarterly total expenses year-on-year change?

Over the past year, ESPR quarterly total expenses has changed by +$6.16 M (+10.01%)